With a recent coveted accreditation, Primary Health Care Corporation’s (PHCC) laboratories have become one of the world’s largest group of network laboratories accredited by the College of American Pathologists (CAP) outside the USA and also the largest conglomerate in the public sector with such credit, according to Kiran Govindan Kutty, Manager of Laboratory, Clinical Operations at PHCC.
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care
E-Mail
ROCKVILLE, Md. - June 10, 2021 - The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care. The manuscript, Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics and Personalized Therapy, was released online ahead of publication in The
Journal of Molecular Diagnostics.
CORE Diagnostics bags accreditation from College of American Pathologists
CORE Diagnostics bags accreditation from College of American Pathologists
09 June 2021 | News CORE Diagnostics becomes one of the nearly 8,000 CAP-accredited facilities worldwide and one of only fourteen standalone labs in India
www.shutterstock.com
CORE Diagnostics has recently received an accreditation certification from the College of American Pathologists (CAP), a leading international laboratory accrediting organisation, based on the results of a recent assessment as part of the CAP’s Accreditation Programs.
Commenting on the accomplishment, Dinesh Chauhan, CEO, CORE Diagnostics, said, “This is another step in our company’s expansion plans and towards offering best-in-class diagnostic accuracy while complying with rigorous criteria of quality assurance to all.”
IHH’s laboratory arm receive accreditation from CAP 07 Jun 2021 / 11:20 H. -From Pantai Premier Pathology’s Facebook page
KUALA LUMPUR: IHH Healthcare Malaysia’s laboratory arm, Pantai Premier Pathology, is one of only two laboratories in Malaysia to receive an accreditation from the College of American Pathologists (CAP).
The honour goes to its Cytogenetics and Molecular Diagnostic Laboratory that specialises in Molecular Oncology, Cytogenetics and Molecular Infectious Disease, IHH said in a statement today.
“CAP, through its expert teams of multi-disciplinary laboratory professionals, conducted a detailed and customised evaluation which attests that test results and patient diagnoses from Pantai Premier Pathology are highly accurate.